SCORED and SOLOIST trials add to evidence for treating diabetes with SGLT2 inhibitors

SCORED and SOLOIST trials add to evidence for treating diabetes with SGLT2 inhibitors

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes...
read more